Efficacy and Safety of Volenrelaxin in Adults With Chronic Kidney Disease
Public ClinicalTrials.gov record NCT06598631. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Volenrelaxin in Adults With Chronic Kidney Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main purpose of this study is to investigate the efficacy and safety of Volenrelaxin in adults with Chronic Kidney Disease. The study will last about 24 weeks.
Study identification
- NCT ID
- NCT06598631
- Recruitment status
- Withdrawn
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2024
- Primary completion
- Nov 30, 2024
- Completion
- Nov 30, 2024
- Last update posted
- Sep 7, 2026
2024
United States locations
- U.S. sites
- 16
- U.S. states
- 7
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Rancho Research Institute | Downey | California | 90242 | — |
| Southwest Nephrology Associates | Evergreen Park | Illinois | 60805 | — |
| Nephrology Associates of Northern Illinois and Indiana (NANI) - Hinsdale | Hinsdale | Illinois | 60521 | — |
| Nephrology Associates of Northern Illinois and Indiana (NANI) - Huntley | Huntley | Illinois | 60142 | — |
| Nephrology Associates of Northern Illinois and Indiana (NANI) - Fort Wayne | Fort Wayne | Indiana | 46804 | — |
| Nephrology Associates of Northern Illinois and Indiana - IKS - Indianapolis South | Indianapolis | Indiana | 46227 | — |
| Diabetes and Metabolism Associates, APMC | Metairie | Louisiana | 70006 | — |
| Elite Clinical Research Center | Flint | Michigan | 48532 | — |
| Eastern Nephrology Associates - Greenville | Greenville | North Carolina | 27834 | — |
| Eastern Nephrology Associates | Jacksonville | North Carolina | 28546 | — |
| Eastern Nephrology Associates- Kinston Office | Kinston | North Carolina | 28504 | — |
| Lucas Research, Inc. | Morehead City | North Carolina | 28557 | — |
| Eastern Nephrology Associates- New Bern Office | New Bern | North Carolina | 28562 | — |
| Eastern Nephrology Associates - Wilmington | Wilmington | North Carolina | 28401 | — |
| Endocrine Associates | Houston | Texas | 77004 | — |
| Permian Research Foundation | Odessa | Texas | 79761 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06598631, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 7, 2026 · Synced Sep 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06598631 live on ClinicalTrials.gov.